Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$69.39 - $97.64 $36,082 - $50,772
-520 Reduced 10.28%
4,537 $362 Million
Q4 2023

Feb 08, 2024

BUY
$57.42 - $83.61 $290,372 - $422,815
5,057 New
5,057 $402 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Harmony Asset Management LLC Portfolio

Follow Harmony Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harmony Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harmony Asset Management LLC with notifications on news.